Symptom Trajectories in Patients With Anxiety Disorders During Transdiagnostic Cognitive Behavioral Therapy
Depression and Anxiety · 2026-01 · 2026 (1)
DOI: 10.1155/da/2743962 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Depression and Anxiety, online erschienen am 21.07.2026. Verfasst von Laura E Meine und 7 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Psychopathology and Psychotherapy, Department of Psychology, University of Zurich, Zurich, Switzerland, uzh.ch. Hauptthemen laut MEDLINE: Anxiety Disorders, Cognitive Behavioral Therapy, Outcome Assessment, Health Care. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Growing research confirms the efficacy of transdiagnostic cognitive behavioral psychotherapy, that is treatments applicable across multiple diagnoses within a disorder class or spectrum, by examining group‐level changes from pre‐ to posttreatment. However, less is known about interindividual differences and dynamic changes during therapy. Understanding different symptom trajectories and their associations with treatment outcome would allow early detection of nonresponders and treatment adjustments. Using data from the treatment group of a randomized controlled trial, we aimed to investigate trajectories in transdiagnostic cognitive behavioral therapy (CBT) with the Unified Protocol (UP) in patients with anxiety disorders. Patients reported on demographics, clinical history, coping strategies, treatment motivation, and expectations before starting transdiagnostic CBT. Participants provided symptom ratings across 16 sessions of the UP as well as at posttreatment, 6‐, and 12‐month follow‐up ( N = 64, 71.9% female, age: M = 32.67, SD = 11.91). Using latent class growth analysis (LCGA), we identified symptom trajectory classes and tested whether these could be predicted from baseline data. We also examined associations between classes and treatment outcome, using multilevel modeling and reliable change indices (RCIs). LCGA revealed four distinct trajectory classes: low severity—improved ( n = 21, 32.81%), high severity—improved ( n = 19, 29.69%), high severity—stagnant ( n = 12, 18.75%), and low severity—worsened ( n = 12, 18.75%). Only the number of comorbidities emerged as a significant predictor of class, with patients in the high severity—stagnant group having more comorbidities. They also showed higher symptom severity at baseline, posttreatment, and follow‐ups compared to other classes, despite clear improvement. Latent classes of symptom changes during transdiagnostic CBT can be distinguished and important pretreatment factors identified, informing treatment selection and personalization. Particularly patients with high initial burden and a higher number of comorbidities may require monitoring and adaptive treatment strategies, which should be explored in future studies. Trial Registration: ClinicalTrials.gov identifier: NCT03945617
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Psychopathology and Psychotherapy, Department of Psychology, University of Zurich, Zurich, Switzerland, uzh.ch.
- Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Zurich, Switzerland.
- Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany, fu-berlin.de.
- Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA, med.nyu.edu.
ORCID-Profile: Laura E Meine, Carmen Schaeuffele, Dominique Recher, Miriam Müller-Bardorff, Christina Paersch, Ava Schulz, Isaac Galatzer-Levy, Birgit Kleim
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Meine, L. E., Schaeuffele, C., Recher, D., Müller-Bardorff, M., Paersch, C., Schulz, A., Galatzer-Levy, I., & Kleim, B. (2026). Symptom Trajectories in Patients With Anxiety Disorders During Transdiagnostic Cognitive Behavioral Therapy. Depression and Anxiety, 2026(1). https://doi.org/10.1155/da/2743962
Vancouver
Meine LE, Schaeuffele C, Recher D, Müller-Bardorff M, Paersch C, Schulz A, et al. Symptom Trajectories in Patients With Anxiety Disorders During Transdiagnostic Cognitive Behavioral Therapy. Depression and Anxiety. 2026;2026(1). doi:10.1155/da/2743962
BibTeX
@article{Meine2026,
author = {Meine, Laura E and Schaeuffele, Carmen and Recher, Dominique and Müller-Bardorff, Miriam and Paersch, Christina and Schulz, Ava and Galatzer-Levy, Isaac and Kleim, Birgit},
title = {Symptom Trajectories in Patients With Anxiety Disorders During Transdiagnostic Cognitive Behavioral Therapy},
journal = {Depression and Anxiety},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/da/2743962}
}
EUVIMED